Cargando…

MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study

BACKGROUND: Myosin light chain plays a vital regulatory function in a large-scale cellular physiological procedure, however, the role of myosin light chain 5 (MYL5) in breast cancer has not been reported. In this study, we aimed to elucidate the effects of MYL5 on clinical prognosis and immune cell...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lv, Minghe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957649/ https://www.ncbi.nlm.nih.gov/pubmed/36846347 http://dx.doi.org/10.1155/2023/9508632

Ejemplares similares

The landscape of prognostic and immunological role of myosin light chain 9 (MYL9) in human tumors
por: Lv, Minghe, et al.
Publicado: (2021)

WD repeat domain 6 as a novelty prognostic biomarker correlates with immune infiltration in lung cancer: A preliminary study
por: Lv, Minghe
Publicado: (2022)

TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer
por: Guo, Chenming, et al.
Publicado: (2023)

MYBPC2 and MYL1 as Significant Gene Markers for Rhabdomyosarcoma
por: Chen, Zihang, et al.
Publicado: (2021)

Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC
por: Li, Ce, et al.
Publicado: (2023)

Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma
por: Wang, Jian-Hua, et al.
Publicado: (2017)

GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer
por: Yang, Yan, et al.
Publicado: (2021)

CCDC69 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration
por: Yi, Yi, et al.
Publicado: (2022)

MYL-1402O: A Bevacizumab Biosimilar
por: Lee, Arnold
Publicado: (2021)

Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2
por: Zhu, Jinyu, et al.
Publicado: (2021)

NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer
por: Yi, Lili, et al.
Publicado: (2022)

MYL2 as a potential predictive biomarker for rhabdomyosarcoma
por: Wang, Junning, et al.
Publicado: (2021)

Correction to: MYL-1402O: A Bevacizumab Biosimilar
por: Lee, Arnold
Publicado: (2022)

JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer
por: Chen, Bo, et al.
Publicado: (2019)

KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration
por: Wang, Zhi, et al.
Publicado: (2021)

PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer
por: Wang, Zonghan, et al.
Publicado: (2023)

HSPA5 Could Be a Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer
por: Zhang, Chao, et al.
Publicado: (2022)

Autosomal recessive cardiomyopathy and sudden cardiac death associated with variants in MYL3
por: Osborn, Daniel Peter Sayer, et al.
Publicado: (2020)

PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer
por: Li, Guang, et al.
Publicado: (2021)

ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Rongqiang, et al.
Publicado: (2021)

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
por: Matsushita, Katsunori, et al.
Publicado: (2021)

MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
por: Hoy, Sheridan M.
Publicado: (2020)

Valsartan inhibits RhoA-ROCK2-MYL pathway in rat model of alcoholic cardiomyopathy
por: Li, Luyifei, et al.
Publicado: (2019)

MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner
por: Deng, Shenghe, et al.
Publicado: (2023)

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity
por: Iwamura, Chiaki, et al.
Publicado: (2022)

The Bidirectional Regulation between MYL5 and HIF-1α Promotes Cervical Carcinoma Metastasis
por: Zhang, Lan, et al.
Publicado: (2017)

T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme
por: Qi, Chunxiao, et al.
Publicado: (2021)

Identification of GGT5 as a Novel Prognostic Biomarker for Gastric Cancer and its Correlation With Immune Cell Infiltration
por: Wang, Yuli, et al.
Publicado: (2022)

Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
por: Zhang, Hao, et al.
Publicado: (2021)

Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer
por: Li, Jiaying, et al.
Publicado: (2023)

Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”
por: Li, Guang, et al.
Publicado: (2021)

TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer
por: Hao, Tao, et al.
Publicado: (2022)

Molecular Mechanism of MYL4 Regulation of Skeletal Muscle Development in Pigs
por: Xu, Xueli, et al.
Publicado: (2023)

Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
por: Hoy, Sheridan M.
Publicado: (2020)

MCTS1 as a Novel Prognostic Biomarker and Its Correlation With Immune Infiltrates in Breast Cancer
por: Deng, Mei, et al.
Publicado: (2022)

Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates
por: Fang, Yutong, et al.
Publicado: (2022)

LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma
por: Wang, Shan, et al.
Publicado: (2022)

SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer
por: Huo, Qin, et al.
Publicado: (2020)

Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer
por: Zhou, Xin‐Ying, et al.
Publicado: (2022)

BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration
por: Xu, Linlong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l06bj14nbio8clhovht97pl018